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Abstract
Background: The endotoxin level in the portal and peripheral veins of hepatocellular carcinoma (HCC) patients is
higher and lipopolysaccharide (LPS), a cell wall constituent of gram-negative bacteria, has been reported to inhibit
tumor growth. However, in this study, we found that LPS-induced toll-like receptor 4 (TLR4) signaling was involved
in tumor invasion and survival, and the molecular mechanism was investigated,
Methods: Four HCC cell lines and a splenic vein metastasis of the nude mouse model were used to study the
invasion ability of LPS-induced HCC cells and the epithelia-mesenchymal transition (EMT) in vitro and in vivo.
A total of 106 clinical samples from HCC patients were used to evaluate TLR4 expression and analyze its
association with clinicopathological characteristics
Results: The in vitro and in vivo experiments demonstrated that LPS could significantly enhance the invasive
potential and induce EMT in HCC cells with TLR4 dependent. Further studies showed that LPS could directly
activate nuclear factor kappa B (NF-B) signaling through TLR4 in HCC cells. Interestingly, blocking NF-B signaling
significantly inhibited transcription factor Snail expression and thereby inhibited EMT occurrence. High expression
of TLR4 in HCC tissues was strongly associated with both poor cancer-free survival and overall survival in patients.
Conclusions: Our results indicate that TLR4 signaling is required for LPS-induced EMT, tumor cell invasion and
metastasis, which provide molecular insights for LPS-related pathogenesis and a basis for developing new
strategies against metastasis in HCC.
Keywords: Toll-like receptor 4, Epithelial-mesenchymal transition, Lipopolysaccharide, Human hepatocellular
carcinoma
Background
Persistent inflammatory conditions can induce tumorigen-
esis [1]. Hepatocellular carcinoma (HCC) is closely asso-
ciated with chronic inflammatory liver diseases and the
endotoxin level in the portal and peripheral veins of those
patients is higher owing to changes in the intestinal muco-
sal permeability and increased bacterial infection [2-4].
Lipopolysaccharide (LPS), a cell wall constituent of gram-
negative bacteria, is released during lysis of bacteria. It
has been reported that LPS can induce cytokines from
immune cells and inhibit tumor growth [5,6], but recent
studies have shown that LPS can alter cytokine levels in
the tumor microenvironment and exert direct effects on
tumor cell proliferation, invasion and metastasis in vitro
and in vivo [7-10].
Toll-like receptor 4 (TLR4), the receptor for LPS, is not
only important in the regulation of immune responses to
infection [11], but also is involved in noninfectious
inflammatory diseases, such as tumor invasion and survi-
val [12]. TLR4 has been detected in many human cancer
cell lines, including pancreatic, lung, breast, prostate,
liver and colorectal cancer [10,12-16]. When silencing
TLR4 expression, the invasion, survival, and tumorigeni-
city of human prostate cancer cells was inhibited, which
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indicates TLR4 plays a significant role in connecting
inflammation and cancer invasion and progression [12];
however, the exact mechanism is still not clear.
Epithelial to mesenchymal transition (EMT) is a process
in which epithelial cell layers lose polarity together with
cell to cell contacts which results in a dramatic remodeling
of the cytoskeleton, and has an important role in tumor
metastasis [17]. When human intrahepatic biliary epithe-
lial cells (IBECs) were exposed to high levels of LPS, the
IBECs could undergo EMT, potentially contributing to
hepatic fibrosis or even hepatoma [18]. In HCC tissues,
LPS was previously reported to promote adhesion and
invasion in hepatoma cells [9]. These effects suggest that
LPS-induced TLR4 signaling provides a survival benefit
for metastatic tumors; however, whether TLR4 signaling
can induce EMT in HCC cells and the mechanism
involved remains unclear.
In the present study, we provide evidence that LPS-
induced TLR4 signaling promotes HCC cell invasion and
EMT in vitro and in vivo, and a high expression of TLR4
in HCC tissues was strongly associated with both poor
cancer-free survival and overall survival in patients, which
indicates that LPS is closely related to tumor invasion and
metastasis, rather than only anti-tumor effects.
Methods
Reagents and antibodies
(Dulbecco’s) modified Eagle’s medium ((D)MEM), fetal
bovine serum (FBS), penicillin, streptomycin sulfate, gluta-
mine, and 0.05% trypsin/0.02% ethylenediamine tetraacetic
acid (EDTA) solution were purchased from Invitrogen
(Carlsbad, CA, USA). LPS derived from Escherichia coli
strain 055:B5, Trizol, Lipofectamine 2000 and BAY11-7028,
the inhibitor of nuclear factor kappa B (NF-B), were pur-
chased from Sigma (St. Louis, MO, USA). A dual luciferase
reporter gene assay kit to detect NF-B activity was pur-
chased from Promega (Madison, WI, USA). Rabbit anti-
human E-cadherin and Vimentin antibodies were obtained
from Thermo (Fremont, CA, USA). Goat anti-human Snail
antibody was purchased from R&D (Minneapolis, MN,
USA). Rabbit anti-human TLR4 antibody was purchased
from Bioworld Technology (St. Louis, MN, USA).
Cell lines and culture condition
HCC cell lines (HepG2, Huh7, Hep3B, SMMC-7721 and
MHCC97-H) were cultured in (D)MEM supplemented
with 10% FBS, 100 U/ml penicillin, 100 μg/ml streptomy-
cin sulfate, and 2.0 mM glutamine. Cells were maintained
at 37°C in a humidified 5% CO2 atmosphere and subcul-
tured by trypsinization with 0.05% trypsin/0.02% EDTA
when cells became confluent. For LPS treatment, subcon-
fluent cultures of cells were treated with 10 μg/ml LPS for
48 hours. For NF-B inhibition, 10 μM BAY11-7028 was
added to the cell culture at the same time as LPS.
Patients and tissue specimens
Specimens of HCC tissues were obtained from 106 HCC
patients who underwent hepatic resection at the Eastern
Hepatobiliary Surgery Hospital of the Second Military
Medical University from October 2000 to November
2003. These patients included 88 men and 18 women
with a median age of 49 years (range: 11 to 72), and all
of the specimens were subjected to immunohistochem-
isty (IHC). Prior informed consent was obtained and the
study protocol was approved by the Ethics Committee
of the Eastern Hepatobiliary Surgery Hospital.
Wound healing and Transwell assay
The methods for wound healing and the Transwell assay
have been described [19-21]. For the wound-healing
assay, cells (5 × 104) were seeded on a 24-well dish and
incubated for 24 hours, the monolayer was then dis-
rupted with a cell scraper (1.2 mm width), and photo-
graphs were taken at 0 and 48 hours in a phase-contrast
microscope. Experiments were carried out in triplicate,
and four fields of each point were recorded. For the
Transwell assay, Boyden chambers (8 μm pore size) were
coated with 200 μl Matrigel at 200 μg/ml and incubated
overnight. Cells (5 × 104) in medium without serum were
plated in the upper chamber, and the medium containing
5% FBS was added in the lower chamber as a chemoat-
tractant. After 24 hours of incubation at 37°C, the cells
were fixed in 4% formaldehyde and stained with crystal
violet dye, and the cells that invaded through the pores
to the lower surface of the filter were counted under a
microscope. Three invasion chambers were used per con-
dition. The values obtained were calculated by averaging
the total number of cells from three filters.
Nude mouse splenic vein metastasis assay
All procedures involving animals were performed in
accordance with the institutional animal welfare guide-
lines of the Second Military Medical University. Cells
were injected into the splenic vein of eight-week-old
nude mice (BALB/c strain) at 1 × 106 cells/injection
site. The mice were sacrificed after six weeks and the
numbers of surface liver metastases were counted.
Quantitative real-time polymerase chain reaction (qPCR)
Total RNA extraction, complementary DNA (cDNA)
synthesis, and qPCR were performed as described [22].
The primer sequences used in qPCR are shown in Addi-
tional file 1 Table S1.
Western-blot analysis
Total soluble protein extractions from cultivated cells
and western-blot analysis were performed as described
[22]. Antibodies used in western-blot experiments were
specific for TLR4, Snail or E-cadherin.
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Immunofluorescence
About 104 cells were seeded on a 48-well dish. After
24 hours, the cells were washed twice with PBS, and
fixed in 4% paraformaldehyde and 0.1% Triton × 100 in
PBS buffer at 4°C for 30 minutes. After being washed
with PBS, the cells were incubated with the blocking
solution (10% goat serum in PBS), and then incubated
overnight with the primary antibodies, washed with PBS,
and finally incubated with secondary antibodies at 37°C
for 2 hours. After being stained with DAPI/PI (4’, 6-dia-
midino-2-phenylindole/ propidium iodide), all matched
samples were photographed using an immunofluores-
cence microscope and identical exposure times.
FACS Analysis
The expression of TLR4 on HCC cells was determined
using indirect immunofluorescent staining. In this analysis,
20 μl of anti-TLR4 antibody were added to 100 μl of cell
suspension (1 × 106 cells/ml) and incubated at 4°C for
30 minutes, and further stained with secondary fluorescein
isothiocyanate (FITC)-conjugated antibody at 4°C for
30 minutes. FITC-conjugated isotype IgG antibody was
used as a negative control. The stained cells were analyzed
on a FACS flow cytometer (Becton Dickinson, San Jose,
CA, USA).
Generation of stable TLR4-expressed and knocked-down
cell lines
The adeno-associated viral construct which directs the
expression of TLR4 (pAAV-TLR4-IRES-GFP), siRNA
against TLR4 (pAAV-siTLR4-IRES-GFP) and their control
vectors were constructed and verified by DNA sequencing.
The adeno-associated viral construct that expresses TLR4
or siRNA targeting TLR4 were co-transfected with adeno-
associated viral packaging plasmids pAAV-RC, pAAV-
helper into 293T cells by Lipofectamine 2000 according to
the manufacturer’s instructions. At 24 and 48 hours post-
transfection, culture medium was collected to be incu-
bated with target cells. At 48 hours post-infection, infected
cells were harvested for gene and protein expression analy-
sis or selected with G418 (400 μg/ml) for two weeks to
establish stable clones.
NF-B luciferase reporter assays
NF-B luciferase reporter assays were performed as
described previously [23]. Briefly, cells were co-transfected
with a pNF-B-luc reporter construct and a renilla lucifer-
ase-expressing plasmid (internal control to normalize for
transfection efficiency) using Lipofectamine 2000 accord-
ing to the manufacturer’s instructions. After treatment for
48 hours, firefly and renilla luciferase activities were
assessed using a dual luciferase reporter gene assay kit.
NF-B transcriptional activity = relative light units of fire-
fly luciferase/relative light units of renilla luciferase.
IHC analysis
The sample processing and IHC procedures were per-
formed as described [20] and the results were expressed as
the percentage of tumor cells with a positive stain. There-
after, the percentage of TLR4-positive tumor cells was
scored on a scale of 0 to 4 (0: no staining; 1: ≤10%; 2: 11%
to 30%; 3: 31% to 50%; 4: ≥50%). Furthermore, the expres-
sion level of TLR4 was divided into the following two
groups according to score: low (0, 1, 2) and high (3, 4)
[16].
Statistical analysis
All data, expressed as mean ± the standard error of the
mean (SEM), were from at least three separate experi-
ments. Groups were compared by analysis of variance
(ANOVA) with a posteriori contrast by least significant
difference; or by Student t-test using the Microsoft Excel
Analysis ToolPak (Microsoft, Redmond, WA). P < 0.05
was considered significant.
Results
LPS induces metastasis and invasion of HCC cells lines
Four different human HCC cell lines (HepG2, Huh7,
Hep3B, and SMMC-7721) were tested for the scratch
wound-healing and Matrigel invasion assay. In HepG2
and Huh9 cells, no obvious effects on motility and inva-
sion were observed in the presence of LPS stimulation
(10 μg/ml) for 48 hours, and the effect in Hep3B cells
was also limited. In contrast, the motility and invasion
abilities of SMMC-7721 cells were enhanced significantly
(Figure 1A, B, P < 0.05). We next chose HepG2, the least
invasive cell line, and SMMC-7721, the most invasive
one, for the splenic vein metastasis assay in vivo. Subcon-
fluent monolayer cultures of cells were treated with or
without LPS for 48 hours, and then were injected intras-
plenically into athymic nude mice. After six to eight
weeks, mice injected with LPS-treated or -untreated
HepG2 cells had no difference in the number of liver sur-
face metastatic nodules; however, the mice injected with
LPS-treated SMMC-7721 cells had a significantly higher
number of liver surface metastatic nodules compared to
those with untreated cells (Figure 1C, D, P < 0.05). The
survival rate of mice showed a similar trend (Figure 1E).
These results indicate that LPS has diverse effects on the
metastatic potential of HCC cell lines.
LPS induces EMT in cells with higher expression of TLR4
Cell scattering was observed in SMMC-7721 cells treated
with LPS, while no phenotypic changes were observed in
the other cell lines (HepG2, Huh7 and Hep3B) (Figure 2A).
Consistent with LPS promoting SMMC-7721 cell invasion,
the mesenchymal markers (Vimentin, N-cadherin, and
a-smooth muscle actin (a-SMA)) were upregulated and
epithelial markers (E-cadherin and b-catenin) were
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downregulated. LPS did not induce EMT in HepG2, Huh7
and Hep3B cells (Figure 2B). The immunofluorescence
results of E-cadherin and Vimentin further support the
finding that LPS induced EMT in SMMC-7721 cells but
not in HepG2 cells (Figure 2C).
LPS-induced metastasis and EMT in HCC cells are
dependent on TLR4
Based on real-time PCR analysis, the HCC cell line
SMMC-7721 cells constitutively expressed a high level of
TLR4, whereas Hep3B cells had low levels; on the other
hand, the expression of TLR4 was almost absent in HepG2
and Huh7 cells (Figure 3A). Furthermore, FACS analysis
showed that LPS had little effect on TLR4 expression
(Figure 3B), suggesting that the different effects of LPS on
HCC cell lines might be associated with intrinsic TLR4
expression. In addition, we detected TLR4 expression of
the hepatocellular carcinoma cell line MHCC97-H cells
which had been confirmed with a strong ability to metasta-
size. The results also showed that MHCC97-H cells
expressed a high level of TLR4 which was not affected by
LPS [See Additional file 1, Figure S1A]. LPS significantly
promoted the invasion of the MHCC97-H cells through
the Matrigel [See Additional file 1, Figure S1B]. The cell
Figure 1 Metastasis and invasion of HCC cells lines in response to LPS. (A) The wound healing assay was employed to determine the
migration of HepG2, Huh7, Hep3B and SMMC-7721 cells in response to LPS. Cells were monitored every 24 hours for two days to evaluate the rate
of migration into the scratched area. (B) Invasiveness of cells was determined using the Transwell assay. Cells were treated with LPS (10 μg/ml) for
48 hours, and then plated in the upper chamber of the Transwell and allowed to grow for 24 hours in serum-free medium, 5% fetal bovine serum
was placed in the lower chamber. The number of cells that invaded through the Matrigel was counted in ten fields under the ×20 objective lens,
and is shown as the mean ± standard deviation (*P < 0.05, **P < 0.01). (A) and (B) are representative of at least three independent experiments
(× 200). (C) Pictures of metastatic liver nodules in nude mice by splenic-vein injection of HepG2 and SMMC-7721 cells untreated or treated with
LPS. H & E staining was performed on serial sections of metastatic tumors and normal liver (× 200). The arrows indicate the metastatic tumor on
the surface of the liver. (D) The numbers of nodules were quantified on nude mice livers (n = 10 per group). Values for individual mice are shown
above the bars (*P < 0.05). (E) Survival rate of nude mice six weeks after splenic vein injection of HepG2 and SMMC-7721 cells untreated or treated
with LPS. HCC, hepatocellular carcinoma; LPS, lipopolysaccharide.
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phenotype was also changed, which indicated that the
mesenchymal markers (Vimentin and N-cadherin) were
upregulated and the epithelial markers (E-cadherin and
b-catenin) were downregulated [See Additional file 1,
Figure S1C, D].
To determine whether TLR4 is important in LPS-induced
tumor cell metastasis and EMT, we used adeno-associated
virus to express TLR4 in HepG2 cells [See, Additional
file 1, Figure S2A, B], then pretreated vec-HepG2 and
TLR4-HepG2 with LPS. The scratch wound-healing and
Matrigel invasion assay showed that overexpression of
TLR4 enhanced LPS-induced motility and invasion of
HepG2, accompanied by EMT (a decreased expression in
epithelial cell markers, such as E-cadherin and b-catenin,
and an increased expression of mesenchymal cell markers,
such as Vimentin, N-cadherin, and a-SMA. (Figure 4A,
B, C). We then knocked down TLR4 in SMMC-7721 cells
with siRNA [See Additional file 1, Figure S 2C, D]; reduc-
tion of TLR4 expression in SMMC- 7721 cells reversed the
changes in cell motility, invasion and EMT induced by LPS.
(Figure 4A, B, C). We next examined whether TLR4
expression influenced LPS-induced tumor cell metastasis in
vivo. Transfected cells were stimulated by LPS for 48 hours
in vitro and then injected intrasplenically into athymic
nude mice. The nude mice splenic vein metastasis models
showed that mice injected with LPS-treated TLR4-HepG2
cells had more metastatic nodules on the liver surface than
mice with LPS-treated vec-HepG2 cells (Figure 4D, E,
Figure 2 LPS induces EMT in SMMC-7721 cells but not others. (A) Phase-contrast photographs showing the morphology of HCC cells
untreated or treated with LPS (10 μg/ml) for 48 h ours (× 200). (B) qPCR was used to detected changes in expression of EMT genes in HCC cells
treated with LPS. Results presented represent mean of triplicate experiments ± SEM (*P < 0.05, **P < 0.01). (C) Immunofluorescent staining of
E-cadherin and Vimentin was performed in HepG2 and SMMC-7721 cells that were either untreated or treated with LPS, nuclei were
counterstained with DAPI (× 200). EMT, epithelial-mesenchymal transition; HCC, hepatocellular carcinoma; LPS, lipopolysaccharide; SEM, standard
error of the mean.
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P < 0.05). Reduced TLR4 expression in SMMC-7221
resulted in fewer liver surface metastatic nodules in mice
compared to mice injected with LPS-treated SMMC-7721
cells (Figure 4D, F, P < 0.05). These results indicate that
LPS-induced cell metastasis and EMT in HCC cells are
TLR4 dependent.
LPS-induced EMT involves NF-B activation and increase
of Snail expression
LPS-induced TLR4 signaling has been shown to activate
the NF-B signaling pathway in various cell types [8,24].
To clarify the relationship between NF-B activation
and the enhanced invasion induced by LPS, we assessed
Figure 3 TLR4 expression in different HCC cells lines. (A) qPCR was used to detected TLR4 mRNA expression in HepG2, Huh7, Hep3B and SMMC-
7721 cells (*P < 0.05). (B) FACS analysis for TLR4 protein in HCC cell lines untreated or treated with LPS (10 μg/ml) for 48 hours. The data shown in
A and B are from one representative experiment of three performed. HCC, hepatocellular carcinoma; LPS, lipopolysaccharide; TLR4, toll-like receptor 4.
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NF-B activation induced by LPS in HepG2 and
SMMC-7721 cells with pNF-B-Luc reporter vector. As
shown in Figure 5A, LPS treatment resulted in a signifi-
cant increase of luciferase activity in SMMC-7721 cells
(P < 0.05), but had no effect in HepG2 cells (P > 0.05).
Translocation of the p65 subunit of NF-B to cell nuclei
and NF-B p65 binding activity were evaluated by
immunofluoresence; after LPS treatment, p65 subunit
translocation significantly increased only in SMMC-7721
cells, whereas no changes were observed in HepG2 cells
(Figure 5B). BAY 11-7082 can inhibit phosphorylation of
IBa and subsequent NF-B nuclear translocation. The
results showed that 10 μM BAY 11-7082 inhibited NF-
B activity induced by LPS in SMMC-7721 cells signifi-
cantly (P < 0.05) but had no effect in HepG2 cells (P >
0.05), which indicated that LPS-induced NF-B activa-
tion is TLR4 dependent.
Margit AH et al. had shown that NF-B is a pivotal reg-
ulator of the EMT process during distinct steps of breast
cancer progression [25]. In our study, we examined how
NF-B activation induced by LPS/TLR4 enhanced expres-
sion of transcription factor Snail (Figure 5C, D), a major
inducer of EMT. Expression of Snail in SMMC-7721 cells
was sufficient to induce EMT as measured by the down
modulation of E-cadherin transcript and protein [See
Additional file 1, Figure S3]. Increased expression of
Snail could also be blocked by treatment with BAY 11-
7082 (Figure 5C, D). Together with the data presented in
Figure 5A, these results showed that treatment with LPS
activated NF-B depending on TLR4 signaling which sub-
sequently caused an increase in Snail and led to EMT and
invasion in HCC cells.
Association of TLR4 expression with clinicopathologic
characteristics and prognosis of HCC
In HCC tissues, a total of 101 of 106 (86%) samples
showed positive TLR4 expression (Figure 6A, B). The
TLR4 expression levels were found to be significantly
higher in HCC tissues with cirrhosis (P = 0.018), tumor
size (P = 0.030), margin (P = 0.019), vascular invasion (P =
0.019), portal vein thrombosis (P = 0.014), and UICC T
stage (P < 0.001) (Table 1). According to the immunohis-
tochemistry results, all 106 HCC patients were divided
into two groups: the high expression group (n = 64) and
low expression group (n = 42) (Figure 6A, B). Most of the
HCC patients within the high expression group had tumor
Figure 4 Alteration of TLR4 influences LPS-induced metastasis and EMT of HCC cells. (A) and (B) HepG2 cells were transduced with
adeno-associated virus to express TLR4 and SMMC-7721 cells were transduced with siRNA to knocked down TLR4, and then the cells were
treated with LPS. The migration of pretreated HCC cells was determined by the wound healing assay (A, × 200) and the invasiveness of
pretreated HCC cells was determined by the Transwell assay (B, × 200). (C) Expression of EMT genes in pretreated HCC cells was detected by
qPCR (normalized to b-actin) Results presented represent the mean of triplicate experiments ± SEM (*P < 0.05, **P < 0.01). (D) Pictures of
metastatic liver nodules in nude mice by splenic-vein injection of pretreated HCC cells (× 200). The arrows indicate the metastatic tumor on the
surface of the liver (n = 10 per group). (E) and (F) The number of nodules was quantified on nude mice livers by splenic-vein injection of
pretreated HCC cells. Values for individual mice are shown above the bars (*P < 0.05). EMT, epithelial-mesenchymal transition; HCC,
hepatocellular carcinoma; LPS, lipopolysaccharide; SEM, standard error of the mean; TLR4, toll-like receptor 4.
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thrombus, and the IHC results showed that TLR4 expres-
sion in tumor thrombus was higher than in normal liver
tissue [See Additional file 1, Figure S4]. In addition, HCC
patients within the high expression group had either worse
cancer-free survival (median cancer-free survival time,
576.83 days versus 1,151.45 days, P < 0.001; Figure 6C) or
worse overall survival (median survival time, 870.45 days
versus 1,689.43 days, P < 0.001; Figure 6D) than those
within the low expression group.
Discussion
To study the key roles of TLR4 in LPS-induced EMT of
HCC cells, we selected four different HCC cells (HepG2,
Huh7, Hep3B, and SMMC-7721) and carefully evaluated
the direct effect of LPS on the invasive potential of these
cells. We demonstrated that LPS could significantly
enhance the invasive potential and induce EMT of HCC
cells with higher expression of TLR4, which was con-
firmed to be in a TLR4 dependent manner. Further studies
showed that LPS could directly activate NF-B signaling
through TLR4 in HCC cells. Importantly, blocking NF-B
signaling significantly inhibited Snail expression and inhib-
ited EMT occurrence. Finally, we revealed that high
expression of TLR4 in HCC tissues was strongly asso-
ciated with both poor cancer-free survival and overall
survival. Our results indicate that TLR4 is necessary for
LPS-induced EMT and metastasis in HCC cells, which
increases our understanding of the pathogenesis and pro-
vides clues for developing new strategies against LPS-
related metastasis of HCC.
This study provides the first evidence that LPS-induced
metastasis and EMT of HCC cells is TLR4 dependent.
EMT is a key event in the metastasis of tumors from
epithelial cells. An imaging study in vivo has shown that
carcinoma cells migrate from mouse primary tumors
through a process of EMT and that this process is depen-
dent on an inflammatory microenvironment [26]. Recently,
the new finding that TNF-a induces EMT in MCF-7 breast
cancer cells reinforced the connection between inflamma-
tion and EMT [27]. In HCC patients, the level of endotoxin
Figure 5 LPS/TLR4 induces cells EMT through activation of NF-B. (A) A dual luciferase assay was performed 48 hours after adding LPS.
Relative NF-kB luciferase activity, normalized to Renilla luciferase activity, was expressed relative to that of control, set at 1.0. LPS resulted in a
significant increase of luciferase activity in SMMC-7721 cells, but had no effect in HepG2 cells; NF-B inhibitors suppress NF-B activation in
SMMC-7721 cells (*P < 0.05). (B) Immunofluoresence was used to evaluate the NF-B p65 binding activity of pretreated HepG2 and SMMC-7721
cells. The p65 subunit of NF-B in the cytosol was stained green and nuclei were stained red with PI (× 400). (C) and (D) qPCR and western-blot
were used to detect Snail expression in pretreated HepG2 and SMMC-7721 cells. The results showed that LPS upregulated Snail expression in
SMMC-7721 cells, but not in HepG2 cells, NF-B inhibitors suppress Snail expression in SMMC-7721 cells (* P < 0.05). EMT, epithelial-
mesenchymal transition; HCC, hepatocellular carcinoma; LPS, lipopolysaccharide; NF-B nuclear factor kappa B; TLR4, toll-like receptor 4.
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in the portal and peripheral veins has been determined to
be higher, which results in a high level of LPS in the portal
vein. In this study, four different human HCC cell lines
(HepG2, Huh7, Hep3B, and SMMC-7721) were tested in
the scratch wound-healing and Matrigel invasion assay.
Our results showed that not all tumor cell lines responded
in vitro to LPS, the motility and invasion abilities of
SMMC-7721 cells were enhanced significantly, and the
data of the splenic vein metastasis assay in vivo were con-
sistent with this. However, Liu et al. have inferred that LPS
may be ignored by immune systems and may directly pro-
mote the invasion abilities of HepG2 and HepG2.2.15 cells
[9]. Our experiment showed that LPS had little effect on
HepG2 cells; the different experimental methods may have
led to the inconsistent results.
Administration of LPS can induce EMT of human
IBECs, which makes tumor cells undergo a phenotypic
change to produce bipolar cells with a fibroblastic mor-
phology. In these four HCC cells, LPS induced EMT in
SMMC-7721 cells but not the others, and SMMC-7721
cells constitutively expressed a high level of TLR4, which
might be associated with LPS-induced metastasis and
EMT of HCC cells. When we used adeno-associated virus
to express TLR4 in HepG2 cells or knocked down TLR4
in SMMC-7721 cells with siRNA, the metastasis and EMT
of HCC cells were changed by being treated with LPS. All
of the above results highlight a direct link between LPS
and tumor cell metastasis. The effect of LPS is possible
because SMMC-7721 cells constitutively express TLR-4.
Not all tumor cells are positive for TLR-4, and this could
depend on the tissue from which the tumor cells origi-
nated. Molteni et al. analyzed the responses of tumor cell
lines from different origins (melanoma, ovarian carcinoma,
neuroblastoma) to LPS in vitro; the results showed that
only melanoma cells significantly increased cell adhesion,
when triggered with LPS and these effects were associated
with the constitutive expression of TLR-4 [28]. Different
HCC cell lines also have different expression of TLR4, and
LPS-induced EMT in cells is in a TLR4 dependent manner
as well. However, notably, HCC development is a multi-
factorial and complicated process, which has a close asso-
ciation with various risk factors, such as viral infection,
alcohol consumption, steatosis, toxic substances and
inflammation. In this process, LPS is an important EMT
inducer but not the only one. Many gene alterations and
cytokines also could induce EMT and promote metastasis
[29]. Therefore, although HCC cells with low expression
or even a lack of TLR4 are not susceptible to LPS, they
might perform EMT induced by other TLR4-independent
mechanisms.
Figure 6 Immunohistochemistry of TLR4 expression in HCC tissues and its prognostic implication. (A) and (B) The membranous expression
of TLR4 was seen to be low in 42/106 of HCC tissues (A), and high in 64/106 (B). Original magnification left × 200, right × 400. (C) Estimated
cancer-free survival according to the expression of TLR4 in 106 cases of HCCs (the Kaplan-Meier method). Log-rank test shows that HCC patients in
the high TLR4 expression group have poorer cancer-free survival than those in the low TLR4 expression group (P < 0.001). (D) Overall survival was
analyzed in the same cohort of HCC patients and the results showed that HCC patients in the high TLR4 expression group also have poorer overall
survival than those in the low TLR4 expression group (P < 0.001). HCC, hepatocellular carcinoma; TLR4, toll-like receptor 4.
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NF-B activation is well known to play an important
role in responses to LPS via TLR-4 [8,24]. Previous stu-
dies have shown that LPS may be able to induce NF-B
activation in colon and pancreatic cancer cells [30,31],
which strongly suggests that LPS can act not only on
immune cells but also on some cancer cells from epithe-
lial cells. In the current study, we found that ligation of
LPS and TLR4 could activate the NF-B pathway in
SMMC-7721 cells, but not in HepG2 cells. Furthermore,
activation of NF-B is involved in the invasion and
metastasis of HCC. Many studies have shown that NF-B
is a key regulator of Snail expression in cancer cell lines
and metastatic tumor samples [32-35]. In our study,
activation of NF-B in SMMC-7721 cells up-regulated
Snail expression, which was a prerequisite for these cells
to undergo an EMT toward an invasive, metastatic tumor
phenotype. Snail is identified as a transcription factor in
the control of EMT, and expression of Snail represses
expression of E-cadherin and induces EMT in breast can-
cer cells, indicating that Snail plays a fundamental role in
EMT [36,37]. To confirm the contribution of NF-B acti-
vation to the enhanced invasive ability and EMT, we
used BAY-11-7082 to inhibit NF-B activation in
SMMC-7721 cells, and the inhibitor not only reduced
NF-B activation, but also down-regulated Snail expres-
sion. Our data strongly suggest that activation of the NF-
B pathway by LPS is TLR4-dependent and increases
Snail expression to induce EMT.
TLR4 expression has been described in different
human tumors [10,12-16]. Gonzalez-Reyes et al. have
showed that TLR4 expression in breast carcinomas was
associated with an increased incidence of metastasis and
has prognostic significance [14]. Cammarota et al. ana-
lyzed 116 tissue samples from patients with different
stages of colorectal disease and found that adenocarci-
noma patients with higher TLR-4 expression in the stro-
mal compartment had a significantly increased risk of
disease progression and relapsed significantly earlier than
those with lower expression levels [38]. Interestingly,
analysis of the association of TLR4 expression and the
clinicopathological characteristics of 106 HCC patients
reveals that TLR4 expression is significantly correlated
with margin, vascular invasion, portal vein thrombosis,
and so on, which are widely accepted markers for metas-
tasis and poor prognosis of HCC [39,40]. The Kaplan-
Meier analysis shows that the HCC patients with high
TLR4 expression in general had a shorter cancer-free
interval and a worse overall survival than those with low
expression, suggesting that TLR4 may be a useful bio-
marker of HCC metastasis and recurrence.
In conclusion, our study has shown for the first time
that LPS-induced EMT and the invasive potential of HCC
cells is in a TLR4 dependent manner and that activation
of the NF-B-Snail regulatory axis may function as a ther-
apeutic target. Furthermore, we have demonstrated that
high expression of TLR4 in HCC tissues significantly cor-
relates with metastasis and recurrence of HCC. Our data
suggest TLR4 as a novel prognostic marker and a potential
therapeutic target for LPS-induced EMT and metastasis of
HCC.
Conclusions
Our results indicate that TLR4 signaling is required for
LPS-induced EMT, tumor cell invasion and metastasis,
which provide molecular insights for LPS-related patho-
genesis and a basis for developing new strategies against
metastasis in HCC.
Table 1 Correlations between TLR4 expression and
clinicopathologic variables of HCC.





≤60 83 36 47 0.134
>60 23 6 17
Gender
Male 88 36 52 0.546
Female 18 6 12
Cirrhosis
Absence 42 17 35 0.018*
Presence 64 35 29
AFP (ng/mL)
≤20 24 11 13 0.479
>20 82 31 51
HBsAg
Negative 15 7 9 0.714
Positive 90 35 55
Tumor size (cm)
≤5 35 19 16 0.030*
>5 71 23 48
Tumor margin
Clear 34 19 15 0.019*
Invovled 72 23 49
Satellite lesion
Absence 77 32 45 0.507
Presence 29 10 19
Vascular invasion
Absence 23 14 9 0.019*
Presence 83 28 55
Portal vein thrombosis
Absence 74 35 39 0.014*
Presence 32 7 25
UICC T stage
T1 16 13 3 <0.001*
T2 60 26 34
T3 30 3 27
(*P <0.05)
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Additional material
Additional file 1: Supplemental figures and tables. Figure S1.
MHCC97-H cells with high expression of TLR4 were induced
metastasis and EMT by LPS. (A) FACS analysis for TLR4 expression in
MHCC97-H cell line untreated or treated with LPS (10 μg/ml) for 48 hours.
(B) The invasiveness of MHCC97-H cells pretreated with LPS (10 μg/ml) for
48 hours was determined by Transwell assay (× 200, *P < 0.05). (C) qPCR
was used to detected changes in the expression of EMT genes in MHCC97-
H cells treated with LPS. Results presented represent mean of triplicate
experiments ± SEM (*P < 0.05). (D) Immunofluorescent staining of E-
cadherin and Vimentin was performed in MHCC97-H cells that were either
untreated or treated with LPS, nuclei were counterstained with DAPI (×
400). Figure S2. Upregulation of TLR4 expression in HepG2 cells and
downregulation of TLR4 expreesion in SMMC-7721 cells. (A) and (B)
Adeno-associated virus was used to express TLR4 in HepG2 cells. TLR4
mRNA expression was detceted by qPCR (A, *P < 0.05) and protein
expression was detected by western-blot (B). (C) and (D) siRNA was used to
knock down TLR4 expression in SMMC-7721 cells. TLR4 mRNA expression
was detceted by qPCR (C, *P < 0.05) and protein expression was detceted
by western-blot (D). Figure S3. Upregulation of Snail induced EMT in
SMMC-7721 cells. Adeno-associated virus was used to express Snail in
SMMC-7721 cells. E-cad mRNA expression was detected by qPCR (A*P <
0.05), and E-cad protein expression was evaluated by western-blot (B). The
data shown in A and B are from one representative experiment of three
performed. Figure S4. High expression of TLR4 in HCC thrombus. (A) H
& E staining was performed to show thrombus in HCC tissues (× 200). (B)
Immunohistochemistry was performed to show TLR4 expression in HCC
thrombus as well as surrounding normal liver tissue (× 200), (a) HCC
thrombus, original magnification × 400 (b) normal liver tissue, original
magnification ×400. BV, blood vessels; T, thrombus; N, normal liver tissue.
Table S1. Description: Sequence of the oligonucleotides for real-time PCR
assays
Abbreviations
ANOVA: analysis of variance; α-SMA: α-smooth muscle actin; (D)MEM:
(Dulbecco’s) modified Eagle’s medium; EDTA: ethylenediamine tetraacetic
acid; EMT: epithelial to mesenchymal transition; FBS: fetal bovine serum;
FITC: fluorescein isothiocyanate; HCC: hepatocellular carcinoma; IBECs:
intrahepatic biliary epithelial cells; IHC: immunohistochemisty; LPS:
lipopolysaccharide; NF-κB; nuclear factor kappa B; qPCR: quantitative real-
time polymerase chain reaction; SEM: standard error of the mean; TLR4: toll-
like receptor 4.
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